{"id":"NCT00988156","sponsor":"Bial - Portela C S.A.","briefTitle":"Eslicarbazepine Acetate (BIA 2 093) as Therapy for Refractory Partial Seizures in Children","officialTitle":"Efficacy and Safety Study of Eslicarbazepine Acetate (BIA 2 093) as Adjunctive Therapy for Refractory Partial Seizures in Children","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12-07","primaryCompletion":"2012-08-20","completion":"2017-08-24","firstPosted":"2009-10-02","resultsPosted":"2014-07-17","lastUpdate":"2018-11-13"},"enrollment":304,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Partial Epilepsy in Children and Adolescents"],"interventions":[{"type":"DRUG","name":"Eslicarbazepine acetate (BIA 2-093)","otherNames":["BIA 2093"]},{"type":"DRUG","name":"Eslicarbazepine acetate","otherNames":["BIA 2093"]}],"arms":[{"label":"Eslicarbazepine acetate","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to examine the efficacy and safety of Eslicarbazepine acetate (BIA 2-093) when given with other anti-epileptic drugs to treat children with partial seizures whose condition has not been controlled by other drug treatments.","primaryOutcome":{"measure":"Change From Baseline in Seizure Frequency","timeFrame":"Baseline up to Visit 7","effectByArm":[{"arm":"Placebo","deltaMin":62,"sd":186.19},{"arm":"Esl (BIA 2-093)","deltaMin":36.6,"sd":72.47}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2490"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":9},"locations":{"siteCount":91,"countries":["Austria","Bosnia and Herzegovina","Croatia","Czechia","France","Germany","Hungary","Italy","Malaysia","Moldova","Philippines","Poland","Portugal","Romania","Russia","Serbia","Slovakia","Spain","Taiwan","Ukraine","United Kingdom"]},"refs":{"pmids":["31878820"],"seeAlso":["https://www.bial.com/en/r_d.2/transparency.208/clinical_trials.209/eslicarbazepine_acetate.210.html","https://www.clinicaltrialsregister.eu/ctr-search/trial/2007-001887-55/results"]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":129},"commonTop":["Nasopharyngitis","Convulsion","Headache","Somnolence","Pharyngitis"]}}